ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

Healthy Weight, Lower Stress May Result In Fewer Changes Associated With Aging

March 27, 2009

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

Blayney Elected ASCO President For 2009.

March 7, 2008

More Workers Quit Smoking When Health Messages Combined

August 30, 2002

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

February 17, 1995